[HTML][HTML] Approved nanomedicine against diseases

Y Jia, Y Jiang, Y He, W Zhang, J Zou, KT Magar… - Pharmaceutics, 2023 - mdpi.com
Nanomedicine is a branch of medicine using nanotechnology to prevent and treat diseases.
Nanotechnology represents one of the most effective approaches in elevating a drug's …

Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery

E Ponzini, C Santambrogio, A De Palma… - Mass Spectrometry …, 2022 - Wiley Online Library
The lacrimal film has attracted increasing interest in the last decades as a potential source of
biomarkers of physiopathological states, due to its accessibility, moderate complexity, and …

Current uses of artificial intelligence in the analysis of biofluid markers involved in corneal and ocular surface diseases: a systematic review

DR Pur, SH Krance, A Pucchio, RN Miranda, T Felfeli - Eye, 2023 - nature.com
Corneal and ocular surface diseases (OSDs) carry significant psychosocial and economic
burden worldwide. We set out to review the literature on the application of artificial …

Impact of diquafosol ophthalmic solution on tear film and dry eye symptom in type 2 diabetic dry eye: a pilot study

Q Zhang, H Zhang, G Qin, Y Wu, Y Song… - Journal of Ocular …, 2022 - liebertpub.com
Purpose: Diquafosol ophthalmic solution (DQS) stimulates P2Y2 receptors on the ocular
surface, which enhances mucin secretion from goblet cells. Therefore, tear film stability and …

Dry eye disease and proteomics

CJ Jackson, KG Gundersen, L Tong, TP Utheim - The Ocular Surface, 2022 - Elsevier
I. Abstract Dry eye disease (DED) is a highly prevalent disease worldwide mostly associated
with age, though other factors such as screen use and contact lens wear explain why it is …

[HTML][HTML] Tear proteomics in dry eye disease

R Kannan, S Das, R Shetty, L Zhou… - Indian Journal of …, 2023 - journals.lww.com
Dry eye disease (DED) is a multi-factorial ocular surface condition driven by compromised
ocular lubrication and inflammation which leads to itching, dryness, and vision impairment …

Effectiveness of topical cyclosporin a 0.1%, Diquafosol Tetrasodium 3%, and their combination, in Dry Eye Disease

Y Eom, JS Song, HM Kim - Journal of Ocular Pharmacology and …, 2022 - liebertpub.com
Purpose: To compare the effectiveness of the topical use of cyclosporin A (CsA) 0.1%,
diquafosol (DQS) tetrasodium 3% ophthalmic solution, and their combination in treating dry …

[HTML][HTML] Assessment and management of dry eye disease and meibomian gland dysfunction: providing a Singapore framework

L Tong, L Lim, D Tan, WJ Heng, J Lim, C Chan… - Asia-Pacific Journal of …, 2021 - Elsevier
The purpose of this article is to provide a framework for general ophthalmologists in
Singapore to manage dry eye. This framework considers the evidence in the literature as …

Effects of diquafosol sodium ophthalmic solution on tear film matrix metallopeptidase-9 and corneal nerve density in patients with type 2 diabetic dry eye

G Qin, J Chen, L Li, Y Qi, Y Chen, Q Zhang… - Journal of Ocular …, 2023 - liebertpub.com
Purpose: Diabetes mellitus has been associated with increased dry eye disease (DED) and
exacerbates DED's pathology. This preliminary short-term study aimed to evaluate the …

Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review

A Pucchio, SH Krance, DR Pur, J Bhatti, A Bassi… - Graefe's Archive for …, 2024 - Springer
Purpose This scoping review summarizes the applications of artificial intelligence (AI) and
bioinformatics methodologies in analysis of ocular biofluid markers. The secondary objective …